Enterome presents Phase 2 indolent non-Hodgkin lymphoma data at EHA showing EO2463 induces B cell target-specific CD8 T-cell expansion correlating with clinical outcomes

Interim results from SIDNEY Phase 2 trial show EO2463 rapidly induced extensive in vivo expansion of B cell target-specific CD8 ...
WebMD

How Zynlonta Works for B-Cell Lymphoma

How Does Zynlonta Work for B-Cell Lymphoma? Zynlonta is an antibody drug conjugate (ADC), which is a type of targeted cancer medicine. ADCs work as smart bombs to find cancer cells in the body that ...
Healthline

Possible Complications of B-Cell Lymphoma

B-cell lymphoma may cause abdominal swelling, chest pressure, and bone weakening as lymphoma cells affect different organs. Treatments like chemotherapy and immunotherapy for B-cell lymphoma may ...
Targeted Oncology

Considerations for CAR T Therapy in R/R Large B-Cell Lymphoma

During a live event, Paolo Strati, MD and participants explore when to use CAR T in relapsed LBCL, how bispecific antibodies ...
Nature

B-cell lymphoma

B-cell lymphoma is a type of cancer originating from abnormal growth and proliferation of B lymphocytes and can be divided into different sub-types including diffuse large B-cell lymphoma (DLBCL), ...
GlobalData on MSN

ModeX starts dosing in MDX2003 trial for B-cell lymphoma

The trial includes dose-escalation and dose-expansion segments.
Labroots

Protein Inhibition Found to Sensitize Aggressive Lymphoma to Therapy

Non-Hodgkin lymphoma (NHL) is a group of hematologic malignancies that originate from lymphocytes known as B or T cells. This ...
WebMD

Breyanzi for Large B-Cell Lymphoma

Has come back (relapsed) within a year of treatment or does not go away (refractory) after your first treatment Has relapsed or is refractory and you cannot receive a hematopoietic stem cell ...